Unlock the power of cutting-edge pathogen detection with Clarity Lab Solutions’ Respiratory Panel Testing, designed to address a broader spectrum of respiratory pathogens simultaneously. RespiCheck specifically identifies influenza viruses, non-influenza viruses, Coronaviruses, and bacterial targets associated with respiratory tract infections.
Benefit from swift turnaround times and precise multi-target identification, empowering healthcare providers to promptly and accurately initiate treatment. This capability holds the potential to mitigate the severity and duration of infections, ensuring optimal patient care.
Flexible Testing Solutions: Choose from our RespiCheck panels featuring two viral, one bacterial, and one flu/RSV panel, along with the option to include a COVID-19 test for comprehensive respiratory testing tailored to your patient’s needs
Provides an accurate, reliable platform for identification of a broad range of common and opportunistic respiratory pathogens
24 hour turnaround time for results
The RespiCheck testing options allows for a fully customized patient experience
We Support Better Outcomes™
The sensitivity of molecular testing is far superior to conventional screening methods because we utilize PCR (Polymerase Chain Reaction) technology that allows small quantities of nucleic acid to be amplified into detectable levels
Due to the limitations of screening tests, negative and positive flu screens alike should be verified and differentiated by molecular testing
Co-infections are a growing concern that require broad and effective pathogen detection
Upper and lower respiratory tract infections are caused by a broad range of microbes and yet are often symptomatically similar, so quick identification is key to successful treatment
Our lab offers a wide array of molecular tests, fast turnaround times, and a local concierge service for your practice.
Discover all the advantages of our innovative approach and how they stack up with your current provider.
In a value-based care model, patient experience takes prime priority. It’s an element that extends beyond just the quality of treatment and encompasses various ancillary services, including the value provided by clinical laboratories.
You’ve got something wrong, and you can’t figure out what it is. Then you go to your doctor, who runs a couple of tests, one of which requires a laboratory analysis. And because you don’t feel well, the sooner your physician gets your results, the quicker you can get well. Which laboratory do you want your test sent to?
Approximately 80% of chronic and recurrent microbial infections in the human body are due to bacterial biofilm. Microbial cells within biofilms have shown 10–1000 times more antibiotics resistance than the planktonic cells.
